Hui KM - Search Results

1

An improved pre-clinical patient-derived liquid xenograft mouse model for acute myeloid leukemia.

Her Z, Yong KSM, Paramasivam K, Tan WWS, Chan XY, Tan SY, Liu M, Fan Y, Linn YC, Hui KM, Surana U, Chen Q. Her Z, et al. Among authors: hui km. J Hematol Oncol. 2017 Oct 6;10(1):162. doi: 10.1186/s13045-017-0532-x. J Hematol Oncol. 2017. PMID: 28985760 Free PMC article.

2

Generation of cytokine-induced killer cells from leukaemic samples with in vitro cytotoxicity against autologous and allogeneic leukaemic blasts.

Linn YC, Lau LC, Hui KM. Linn YC, et al. Among authors: hui km. Br J Haematol. 2002 Jan;116(1):78-86. doi: 10.1046/j.1365-2141.2002.03247.x. Br J Haematol. 2002. PMID: 11841399 Free article.

3

Cytokine-induced killer cells: NK-like T cells with cytotolytic specificity against leukemia.

Linn YC, Hui KM. Linn YC, et al. Among authors: hui km. Leuk Lymphoma. 2003 Sep;44(9):1457-62. doi: 10.3109/10428190309178764. Leuk Lymphoma. 2003. PMID: 14565644 Review.

4

Comparative gene expression profiling of cytokine-induced killer cells in response to acute myloid leukemic and acute lymphoblastic leukemic stimulators using oligonucleotide arrays.

Linn YC, Wang SM, Hui KM. Linn YC, et al. Among authors: hui km. Exp Hematol. 2005 Jun;33(6):671-81. doi: 10.1016/j.exphem.2005.03.005. Exp Hematol. 2005. PMID: 15911091 Free article.

5

Characterization of the recognition and functional heterogeneity exhibited by cytokine-induced killer cell subsets against acute myeloid leukaemia target cell.

Linn YC, Lau SK, Liu BH, Ng LH, Yong HX, Hui KM. Linn YC, et al. Among authors: hui km. Immunology. 2009 Mar;126(3):423-35. doi: 10.1111/j.1365-2567.2008.02910.x. Epub 2008 Sep 5. Immunology. 2009. PMID: 18778291 Free PMC article.

6

Cytokine-induced NK-like T cells: from bench to bedside.

Linn YC, Hui KM. Linn YC, et al. Among authors: hui km. J Biomed Biotechnol. 2010;2010:435745. doi: 10.1155/2010/435745. Epub 2010 Mar 30. J Biomed Biotechnol. 2010. PMID: 20368995 Free PMC article. Review.

7

Preclinical evaluation of transcriptional targeting strategy for human hepatocellular carcinoma in an orthotopic xenograft mouse model.

Sia KC, Huynh H, Chung AY, Ooi LL, Lim KH, Hui KM, Lam PY. Sia KC, et al. Among authors: hui km. Mol Cancer Ther. 2013 Aug;12(8):1651-64. doi: 10.1158/1535-7163.MCT-13-0056. Epub 2013 May 29. Mol Cancer Ther. 2013. PMID: 23720769

8

Inhibition of CXCR4/CXCL12 signaling axis by ursolic acid leads to suppression of metastasis in transgenic adenocarcinoma of mouse prostate model.

Shanmugam MK, Manu KA, Ong TH, Ramachandran L, Surana R, Bist P, Lim LH, Kumar AP, Hui KM, Sethi G. Shanmugam MK, et al. Among authors: hui km. Int J Cancer. 2011 Oct 1;129(7):1552-63. doi: 10.1002/ijc.26120. Epub 2011 Jul 20. Int J Cancer. 2011. PMID: 21480220

9

Benzylidene-indolinones are effective as multi-targeted kinase inhibitor therapeutics against hepatocellular carcinoma.

Ho HK, Chua BT, Wong W, Lim KS, Teo V, Ong HT, Chen X, Zhang W, Hui KM, Go ML, Ullrich A. Ho HK, et al. Among authors: hui km. Mol Oncol. 2014 Oct;8(7):1266-77. doi: 10.1016/j.molonc.2014.04.008. Epub 2014 May 2. Mol Oncol. 2014. PMID: 24839937 Free PMC article.

10

Ascochlorin, an isoprenoid antibiotic inhibits growth and invasion of hepatocellular carcinoma by targeting STAT3 signaling cascade through the induction of PIAS3.

Dai X, Ahn KS, Kim C, Siveen KS, Ong TH, Shanmugam MK, Li F, Shi J, Kumar AP, Wang LZ, Goh BC, Magae J, Hui KM, Sethi G. Dai X, et al. Among authors: hui km. Mol Oncol. 2015 Apr;9(4):818-33. doi: 10.1016/j.molonc.2014.12.008. Epub 2015 Jan 5. Mol Oncol. 2015. PMID: 25624051 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

214 results

Search Page

Filters